Hyperion Defi (HYPD) Change in Inventory (2023 - 2024)
Hyperion Defi (HYPD) posted quarterly Change in Inventory of $910197.0 for Q3 2024, up 313.27% quarter-over-quarter from -$426772.0 in Q2 2024.
Hyperion Defi (HYPD) Change in Inventory (2023 - 2024) Analysis & Trends
Hyperion Defi (HYPD) has reported Change in Inventory for 2 consecutive years, with $910197.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Change in Inventory changed N/A year-over-year to $910197.0; the TTM figure through Sep 2024 stood at $1.1 million (changed N/A YoY), while the FY2023 annual figure was $122016.0, changed N/A from the prior year.
- Change in Inventory grew to $910197.0 in Q3 2024 per HYPD's latest filing, from -$426772.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $910197.0 in Q3 2024 and bottomed at -$426772.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 910,197.00 |
| Sep 30, 2024 | 910,197.00 |
| Jun 30, 2024 | -426,772.00 |
| Jun 30, 2024 | -426,772.00 |
| Mar 31, 2024 | 567,598.00 |
| Mar 31, 2024 | 567,598.00 |
| Dec 31, 2023 | 59,502.00 |
| Dec 31, 2023 | 59,502.00 |